Bio-Connect

EpCAM antibody [VU-1D9] (PE-Cy7)

GTX00606-10
GeneTex
ApplicationsFlow Cytometry
Product group Antibodies
TargetEPCAM
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    GeneTex
  • Product Name
    EpCAM antibody [VU-1D9] (PE-Cy7)
  • Delivery Days Customer
    9
  • Application Supplier Note
    FACS: 4 microl reagent / 100 microl of whole blood or 106 cells in a suspension. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
  • Applications
    Flow Cytometry
  • Certification
    Research Use Only
  • Clonality
    Monoclonal
  • Clone ID
    VU-1D9
  • Conjugate
    Double Conjugated
  • Gene ID4072
  • Target name
    EPCAM
  • Target description
    epithelial cell adhesion molecule
  • Target synonyms
    Ber-Ep4, BerEp4, DIAR5, EGP-2, EGP314, EGP40, ESA, HNPCC8, KS1/4, KSA, LYNCH8, M4S1, MIC18, MK-1, MOC-31, TACSTD1, TROP1, epithelial cell adhesion molecule, adenocarcinoma-associated antigen, cell surface glycoprotein Trop-1, epithelial glycoprotein 314, human epithelial glycoprotein-2, major gastrointestinal tumor-associated protein GA733-2, membrane component, chromosome 4, surface marker (35kD glycoprotein), trophoblast cell surface antigen 1, tumor-associated calcium signal transducer 1
  • Host
    Mouse
  • Isotype
    IgG1
  • Protein IDP16422
  • Protein Name
    Epithelial cell adhesion molecule
  • Scientific Description
    This gene encodes a carcinoma-associated antigen and is a member of a family that includes at least two type I membrane proteins. This antigen is expressed on most normal epithelial cells and gastrointestinal carcinomas and functions as a homotypic calcium-independent cell adhesion molecule. The antigen is being used as a target for immunotherapy treatment of human carcinomas. Mutations in this gene result in congenital tufting enteropathy. [provided by RefSeq, Dec 2008]
  • Storage Instruction
    2°C to 8°C
  • UNSPSC
    12352203

References

  • Twigger AJ, Engelbrecht LK, Bach K, et al. Transcriptional changes in the mammary gland during lactation revealed by single cell sequencing of cells from human milk. Nat Commun. 2022,13(1):562. doi: 10.1038/s41467-021-27895-0
    Read this paper
  • Mikami H, Kawaguchi M, Huang CJ, et al. Virtual-freezing fluorescence imaging flow cytometry. Nat Commun. 2020,11(1):1162. doi: 10.1038/s41467-020-14929-2
    Read this paper
  • Yoshida M, Hibino K, Yamamoto S, et al. Preferential capture of EpCAM-expressing extracellular vesicles on solid surfaces coated with an aptamer-conjugated zwitterionic polymer. Biotechnol Bioeng. 2018,115(3):536-544. doi: 10.1002/bit.26489
    Read this paper
  • Kershaw S, Cummings J, Morris K, et al. Optimisation of immunofluorescence methods to determine MCT1 and MCT4 expression in circulating tumour cells. BMC Cancer. 2015,15:387. doi: 10.1186/s12885-015-1382-y
    Read this paper
  • Lyberopoulou A, Aravantinos G, Efstathopoulos EP, et al. Mutational analysis of circulating tumor cells from colorectal cancer patients and correlation with primary tumor tissue. PLoS One. 2015,10(4):e0123902. doi: 10.1371/journal.pone.0123902
    Read this paper
  • Chen HH, Lin MW, Tien WT, et al. High-purity separation of cancer cells by optically induced dielectrophoresis. J Biomed Opt. 2014,19(4):045002. doi: 10.1117/1.JBO.19.4.045002
    Read this paper